# Pasireotide in Hyperinsulinemic Hypoglycemia

> **NCT03053284** · PHASE2 · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Congenital Hyperinsulinism
- Insulinoma
- Hyperinsulinism

## Interventions

- **DRUG:** Pasireotide 0.6Mg Solution for Injection
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT03053284
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04
- **Primary completion:** 2018-01
- **Final completion:** 2018-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding was withdrawn by Sponsor prior to start of study
- **Last updated:** 2021-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03053284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03053284, "Pasireotide in Hyperinsulinemic Hypoglycemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03053284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*